To assess whether ferroptosis mediated the tumor promotion of SFRS9 in CRC cells, we treated HCT116 cells with shSFRS9-1 in the absence or presence of ferroptosis inhibitor ferrostatin-1 and apoptosis inhibitor ZVAD-FMK. Here, SRSF9 is linked to neoplasm.